Hamilton Lane Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-35,791
| Closed | -$56.9K | – | 66 |
|
|
2023
Q1 | $56.9K | Hold |
35,791
| – | – | 0.02% | 59 |
|
|
2022
Q4 | $52K | Hold |
35,791
| – | – | 0.02% | 67 |
|
|
2022
Q3 | $153K | Sell |
35,791
-35,700
| -50% | -$153K | 0.06% | 59 |
|
|
2022
Q2 | $277K | Hold |
71,491
| – | – | 0.11% | 57 |
|
|
2022
Q1 | $340K | Hold |
71,491
| – | – | 0.08% | 61 |
|
|
2021
Q4 | $261K | Hold |
71,491
| – | – | 0.03% | 81 |
|
|
2021
Q3 | $573K | Buy |
+71,491
| New | +$573K | 0.1% | 62 |
|